Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live ... expensively?
Bhatia
S J
SJ
Department of Gastroenterology, TN Medical College, Mumbai.
Kulkarni
S G
SG
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology / Q000382:microbiology*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000191:economics / Q000627:therapeutic use; D006801:Humans
D006635:Histamine H2 Antagonists